Gottschalk can think of no better way to go out

Article

Health battle threatens to end run of 43 straight years at SNM meeting

Health battle threatens to end run of 43 straight years at SNM meeting

In a postscript to the 2006 Cassen Lecture, Dr. Alexander Gottschalk, a nuclear medicine pioneer associated with the development of technetium-99m for diagnostic nuclear medicine, disclosed that he was battling a life-threatening medical condition. He declined to disclose the exact nature of his condition. While Gottshalk remained dry-eyed, several long-time colleagues cried as he voiced a possible farewell.

"Let me close on a personal note," he said. "I am battling a serious medical condition. For medical reasons, this may be my last SNM meeting. If that is true, I will certainly miss seeing my old friends and making new friends. I will miss putting my two bits in during the discussion sessions I go to, but mostly I will miss the terrific science that surrounds us all at this meeting. I firmly believe that nuclear medicine will be a major modality that brings the molecular biologist to the bedside. But if this is the end of a 43-year run, it is hard to think of a better way to go out."

Gottschalk reported in mid-September that his condition had stabilized following therapy, and he felt well. He is scheduled to speak at the RSNA meeting in November. -JB

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.